Skip to Main Content
Services Talent Knowledge
Site Search
Menu

PressRelease

April 7, 2025

Mark Rokow Joins Barclay Damon

Barclay Damon announces Mark Rokow, associate, has joined Barclay Damon’s Tax Practice Area. His primary office is Rochester.

Rokow concentrates his practice on tax matters. He has experience with mergers and acquisitions, specifically evaluating state and local tax exposures related to income and non-income tax, and unclaimed property across all 50 states. Common issues within the field included nexus-generating activities and failure to file state income tax returns, misclassification of products and services for sales tax remittance, unclaimed property and related escheatment, multi-state employment tax withholding, and transfer tax (RETT/CITT) assessments. Mark has experience with both buy- and sell-side transactions for corporations, s-corporations, and disregarded entities.

Prior to joining Barclay Damon, Rokow was an associate in the state and local tax department of the mergers and acquisitions team at Big 4 accounting firm KPMG.

Barclay Damon attorneys team across offices and practices to provide customized, targeted solutions grounded in industry knowledge and a deep understanding of our clients' businesses. With approximately 300 attorneys, Barclay Damon is a leading regional law firm that operates from a strategic platform of offices in Albany, Boston, Buffalo, New Haven, New York City, Rochester, Syracuse, Washington DC, and Toronto. Our firm serves clients across the country and, for some practices, provides US legal services around the globe. For more information, visit our award-winning website at barclaydamon.com.

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

Year-End Focus for 403(b) Plan Sponsors: Two Critical Document Deadlines and Typical Year-End Compliance Review

Alerts

Second Circuit Reverses Award of Attorney's Fees in Coverage Dispute Between Liability Insurers

Alerts

Federal Court Narrows Scope of Insurers' Privilege Claims in COVID-19 Coverage Litigation

Alerts

AstraZeneca Escalates FARXIGA® Audit Demands: What Pharmacies Need to Know Now

Alerts

Update on the Evolving Guidance for H-1B Entry Restrictions Under September 19 Presidential Proclamation

Alerts

Attention Providers! OMIG Audit Update: New Settlement Flexibility at Lower Confidence Payment Restored and DME Protocol Released